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Summary
The cortisol awakening response (CAR), the marked increase in cortisol secretion 
over the first 30–45 min after morning awakening, has been related to a wide range 
of psychosocial, physical and mental health parameters, making it a key variable for 
psychoneuroendocrinological research. The CAR is typically assessed from self-
collection of saliva samples within the domestic setting. While this confers ecological 
validity, it lacks direct researcher oversight which can be problematic as the validity of 
CAR measurement critically relies on participants closely following a timed sampling 
schedule, beginning with the moment of awakening. Researchers assessing the CAR 
thus need to take important steps to maximize and monitor saliva sampling accuracy 
as well as consider a range of other relevant methodological factors. To promote best 
practice of future research in this field, the International Society of 
Psychoneuroendocrinology initiated an expert panel charged with (i) summarizing 
relevant evidence and collective experience on methodological factors affecting CAR 
assessment and (ii) formulating clear consensus guidelines for future research. The 
present report summarizes the results of this undertaking. Consensus guidelines are 
presented on central aspects of CAR assessment, including objective control of 
sampling accuracy/adherence, participant instructions, covariate accounting, 
sampling protocols, quantification strategies as well as reporting and interpreting of 
CAR data. Meeting these methodological standards in future research will create 
more powerful research designs, thus yielding more reliable and reproducible results 
and helping to further advance understanding in this evolving field of research. 
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1. Introduction
Abnormal secretion of the glucocorticoid hormone cortisol as the final product of the 
hypothalamus-pituitary-adrenal (HPA) axis is considered a crucial factor in linking the 
experience of chronic psychosocial stress to adverse effects on health (Chrousos, 
2009). Besides reactivity to acute stressors, changes to the circadian regulation of 
cortisol secretion are considered important in this context (Kondratova and 
Kondratov, 2012; Menet and Rosbash, 2011; Nader et al., 2010). An aspect of 
cortisol regulation that is of special interest to psychoneuroendocrinological (PNE) 
inquiry is the cortisol awakening response (CAR), which describes the marked 
increase in cortisol levels across the first 30–45 min following morning awakening 
(Clow et al., 2004, 2010; Elder et al., 2014; Kudielka and Wüst, 2010). The CAR was 
first systematically described in the mid-1990s (Pruessner et al., 1997) and soon 
gained attention as a favorable biomarker in PNE research due to several 
methodological advantages over previously employed cortisol assessment strategies 
(see section 2). These advantages together with evidence showing unique 
associations of the CAR with psychosocial, psychiatric and health-related parameters 
have resulted in a rapid increase in publications over the past 15 years (see Figure 
1a). 
The CAR combines features of a reactivity index (response to awakening) with 
aspects tied to circadian regulation (occurring roughly at the same time every 24 
hours) making it a fascinating research topic. However, precisely these features also 
make accurate assessment of the CAR a challenging task. When relying on CAR 
data acquired by participants themselves (usually through saliva sampling), validity 
critically relies on participants closely following a timed sampling schedule, beginning 
with the moment of awakening. Inaccurate sample timing can occur easily and can 
substantially bias CAR estimates. Furthermore, a number of other methodological 
factors, such as accounting for covariates, the number and nature of study days and 
the timing of sampling, can markedly affect CAR data. While not all questions 
regarding the role and regulation of the CAR have been adequately solved until now, 
several careful investigations have examined the impact of methodological factors on 
accurate CAR assessment and have recommended strategies for dealing with them 
(described below). Unfortunately, such recommendations have not been widely 
implemented in published CAR research. Figure 1b provides an overview of 
methodological characteristics of such studies, published between 2013 and 2014. It 
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can be seen that the employed methodological standards varied widely between 
investigations, with a high number of studies falling short of previous 
recommendations for best practice in CAR research (e.g., objective control of 
sampling times: Broderick et al., 2004; Kudielka et al., 2003).  
To address this, the International Society of Psychoneuroendocrinology 
(ISPNE) has initiated an expert panel to summarize relevant evidence and collective 
experience on methodological factors affecting CAR assessment. The goal of this 
initiative was to formulate clear consensus guidelines based on current knowledge for 
future studies in this evolving field of research. The present report summarizes the 
results of this undertaking. As a large proportion of CAR research uses salivary 
cortisol assessments in participants’ domestic setting, a particular focus is put on 
methodological challenges in this research context. Given the importance of sample 
time accuracy, the first three sections are devoted to an in-depth discussion of this 
topic, including strategies to increase sampling accuracy by maximizing participant 
adherence. In the subsequent sections a range of further methodological factors are 
covered. In the final section, the derived consensus guidelines are outlined and 
explained.
[Please insert Figure 1 about here]
2. Cortisol awakening response
The CAR is expressed as part of normal, healthy human circadian physiology. 
Deviations from a typical CAR pattern are assumed to mark maladaptive 
neuroendocrine processes. A general review of psychosocial, psychiatric and health-
related correlates of the CAR is beyond the scope of this article (reviews: Chida and 
Steptoe, 2009; Clow et al., 2004; Fries et al., 2009; Kudielka and Wüst, 2010). 
However, as a prerequisite for interpreting such data, some distinct features of the 
CAR need to be acknowledged. It is important to emphasize that, although 
historically the term ‘CAR’ has been used to describe different aspects of post-
awakening cortisol secretion (including overall levels), only the dynamic of post-
awakening cortisol secretion is accurately referred to as the ‘CAR’, i.e., cortisol 
changes occurring due to the awakening response (Clow et al., 2010). A rationale for 
this recommended terminology is laid out in section 2.2. 
2.1 Description and distinctive features
ISPNE CAR consensus
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The CAR represents a sharp increase in cortisol levels across the first 30–45 min 
following morning awakening. In healthy adults, the magnitude of the CAR was found 
to range between a 50–156% increase in salivary cortisol levels (Clow et al., 2004). 
Figure 2a depicts post-awakening cortisol profiles of children, adolescents and 
elderly adults from the first systematic description of the CAR by Pruessner et al. 
(1997). 
The initial finding suggesting that the awakening process stimulates cortisol 
secretion provided an explanation for previous data of poor test-retest reliability in 
clock-time based cortisol assessments during the early morning hours (e.g., Coste et 
al., 1994; Schulz and Knabe, 1994) and suggested that alignment of cortisol 
sampling with awakening would provide a more reliable measure. This notion was 
soon supported by data showing improved test-retest stability of awakening-aligned 
post-awakening cortisol levels across a broad age range (rs between .39 and .67; 
Pruessner et al., 1997). These initial data were viewed as indicating that the CAR 
could be used as a reliable trait biomarker and, hence, investigations over the 
following years mainly focused on inter-individual variability in CAR profiles using 
cross-sectional designs. Such research revealed the CAR to be related to various 
physical and mental health variables, albeit with some inconsistency (review: Chida 
and Steptoe, 2009). More recent evidence illustrated that the CAR also exhibits 
considerable intra-individual variability (see 7.2). Indeed, although twin studies 
consistently found a moderate heritability of the CAR (Kupper et al., 2005; Wüst et 
al., 2000a), the expression of the CAR on a particular day has been estimated to be 
more influenced by state factors than by stable, trait-like influences, including genetic 
factors (Almeida et al., 2009; Hellhammer et al., 2007; Stalder et al., 2010b). Building 
on these data, research also increasingly set out to investigate state correlates of the 
CAR (review: Law et al., 2013). 
[Please insert Figure 2 about here]
The CAR period is embedded within a well-described circadian pattern of cortisol 
secretion, characterized by a cortisol increase prior to awakening, the CAR period 
and a decline of mean cortisol levels over the remaining diurnal phase (Veldhuis et 
al., 1989; Weitzman et al., 1971). Importantly, there is converging evidence 
suggesting that the CAR is relatively distinct from earlier and later components of 
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circadian cortisol secretion. Sleep laboratory research revealed that the CAR is not a 
mere continuation of the pre-awakening cortisol increase but comprises a 
superimposed response to awakening (Wilhelm et al., 2007; see Figure 2b). In 
addition, the CAR was found to be unrelated to cortisol levels during the remainder of 
the day (Edwards et al., 2001a; Maina et al., 2009) or to a latent trait cortisol factor 
inferred from various diurnal samples (Doane et al., 2015). 
Evidence showing that in healthy humans the CAR, but not later diurnal 
cortisol secretion, is sensitive to light exposure further illustrates its distinct nature: 
morning awakening in darkness or dim light reduces the dynamic of the CAR relative 
to awakening in light (Figueiro and Rea, 2012; Scheer and Buijs, 1999). Furthermore, 
winter awakening using a dawn simulator (gradually increasing light levels before 
awakening) has been associated with increased post-awakening cortisol production 
(Thorn et al., 2004). In rodent studies, light-induced effects on glucocorticoid 
secretion were absent following lesions of the suprachiasmatic nucleus (SCN) or in 
SCN-intact mice with adrenal sympathetic denervation (Buijs et al., 2003). Thus, an 
SCN-mediated extra-pituitary pathway has been implicated in regulation of the CAR, 
but is unlikely to affect cortisol secretion over the remainder of the day (review: Clow 
et al., 2010). 
Besides an uncoupling from basal circadian cortisol secretion, research also 
consistently revealed the CAR to be unrelated to cortisol reactivity to experimentally-
induced psychological stress (Bouma et al., 2009; Schmidt-Reinwald et al., 1999). 
This has important implications for the interpretation of CAR data, i.e., indicating its 
distinctness from cortisol reactivity to acute psychological stress. Interestingly, in an 
early study, the CAR was found to be closely related to the cortisol rise following 
ACTH-challenge (r = .63), suggesting that its expression may be influenced by the 
maximal capacity of the adrenal cortex to produce cortisol (Schmidt-Reinwald et al., 
1999). 
Overall, these data highlight the distinct nature of the CAR and suggest that its 
assessment provides added information that may not be derived from other cortisol 
measures. This together with findings of unique associations with psychosocial, 
cognitive and health-related parameters makes the CAR an interesting measure in 
PNE research. Conversely, these data also illustrate that when interpreting 
respective findings, researchers need to be careful not to mistake the CAR for either 
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a marker of general HPA axis activity/basal cortisol secretion or stress-reactive 
cortisol changes (Clow et al., 2010).
2.2 Main components
The CAR is a dynamic phenomenon triggered by the process of morning awakening. 
Strategies for quantifying post-awakening cortisol secretion need to address two 
main underlying components: First, the starting point of the CAR period, i.e., the first 
sample synchronized with the moment of awakening (S1). Second, the actual 
dynamic of the cortisol increase after awakening, i.e., the CAR itself, assessed at set 
intervals after awakening. Importantly, the two components (S1 and CAR) are often 
found to be inversely related, with a lower CAR following a higher S1, and vice versa 
(Adam et al., 2006; Bäumler et al., 2013; Huber et al., 2006; Stalder et al., 2009, 
2010b; Wilhelm et al., 2007; Wüst et al., 2000b). This relationship can likely be 
interpreted as an illustration of the law of initial value (Wilder, 1962).
Clow et al. (2010) reviewed neurophysiological evidence on the regulation of 
morning cortisol secretion and concluded that differential processes are likely to be 
important for the pre-awakening cortisol increase and for the CAR (Clow et al., 2010). 
They thus suggested that separate results should be reported for S1 (i.e., the 
endpoint of the pre-awakening increase) and estimates of the CAR. This is also 
recommended as part of this consensus report (see section 7.4). In addition, 
quantification strategies are in use, which combine information of S1 and the CAR, 
thus providing an index of overall cortisol secretion over the post-awakening period 
(e.g., the AUCG, Pruessner et al., 2003). When using such measures, it is important 
to acknowledge that they are influenced by both underlying components (S1 and the 
CAR). Hence, it is important to refer to respective measures as reflecting total ‘post-
awakening cortisol concentrations’ or similar, but not as measures of the CAR (Clow 
et al., 2010). In line with this reasoning, graphical illustrations in the present article 
focus on depicting S1 and a measure of the CAR, in this instance the area under the 
curve with respect to increase (AUCI, Pruessner et al., 2003). A discussion of 
statistical approaches to quantifying the CAR is provided in section 7.4.
3. Inaccurate sampling: Prevalence and impact
The validity of CAR data critically relies on the temporal accuracy of saliva sampling 
across the post-awakening period. A typical sampling schedule involves taking a first 
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sample immediately after awakening followed by repeated assessments at specified 
times, e.g., at 10 or 15 min intervals over the subsequent 30–60 min. Figure 3a 
illustrates an exemplary CAR sampling schedule. Failure to comply with such a 
schedule can occur in multiple ways. In the following, we distinguish between 
participants (i) failing to correctly report their awakening time and/or delaying the 
initiation of sampling in relation to the moment of awakening and (ii) not adhering to 
the specified time intervals for later sampling. 
3.1. Delay between awakening and initiation of sampling
The commencement of sampling immediately after awakening is crucial for 
accurately capturing the CAR. Table 1a provides an overview of studies examining 
the impact of delayed initiation of sampling after awakening. This research employed 
a range of methods, such as actigraphy, electrocardiography (ECG) or 
polysomnography (PSG), to verify participants’ self-reported times of awakening (see 
4.2.1 for a description of methods). In addition, two recent studies also used 
electronic monitoring devices to verify times of sample collection (Griefahn and 
Robens, 2011; Smyth et al., 2013).
[Please insert Table 1 about here]
The first description of awakening time-related sampling inaccuracy was made in a 
post-hoc analysis carried out on a subgroup of individuals (13.1% of the total sample) 
who failed to show any evidence of a positive CAR (Kupper et al., 2005). By utilizing 
available ECG and actigraphy data, it was revealed that these participants showed a 
mean delay of 42 min (range: 10–135 min) between verified and self-reported 
awakening times. By contrast, participants with regular CAR profiles mostly showed 
good correspondence between self-reported and verified awakening times (Kupper et 
al., 2005). Following these initial data, subsequent research confirmed that failure to 
correctly report the time of awakening and/or to delay the beginning of sampling after 
awakening is relatively common and profoundly impacts CAR estimates (see Table 
1a). Across studies, mean verified awakening times preceded mean self-reported 
awakening times by 3.3–6.2 min and mean self-reported times of collecting S1 by 
7.1–24.8 min (DeSantis et al., 2010; Dockray et al., 2008; Okun et al., 2010). A 
particularly striking illustration of the potential extent of such inaccuracy was reported 
by Griefahn and Robens (2011) who accumulated data from three studies, each 
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employing careful objective verification of awakening and sampling times across 6–8 
days per individual. They found that participants delayed collecting S1 by 3–30 min 
on 19.3% of sampling days and by even >30 min on 14.0% of sampling days 
(Griefahn and Robens, 2011). 
However, delaying the collection of S1 after awakening by more than 15 min results 
in false-high estimates of S1 and false-low estimates of the CAR. This pattern 
emerged both from research relying on self-reports of S1 timing (DeSantis et al., 
2010; Dockray et al., 2008; Okun et al., 2010) and from studies objectively monitoring 
sampling times (Griefahn and Robens, 2011). Figures 3c and d exemplify the impact 
of 20 and 40 min sampling delays, respectively, on estimates of S1 and the CAR 
(AUCI). 
[Please insert Figure 3 about here]
The impact of smaller delays in sampling S1 (<15 min) has been more difficult to 
capture. Earlier research indicated no differences in CAR estimates between fully 
accurate individuals (delays <1 min) and those with 1–15 min delays (Dockray et al., 
2008; Okun et al., 2010). Other studies, however, reported a trend for an attenuated 
CAR in individuals with 5–15 min delays (DeSantis et al., 2010) or suggested that 
CAR estimates already started to decrease with delays exceeding ~10 min (Griefahn 
and Robens, 2011). An important addition to these data comes from recent research 
by Smyth et al. (2013, 2015): employing careful control of awakening and sampling 
times in healthy participants (sampling at 5 min intervals), their findings revealed that 
minor delays (5–15 min) yielded estimates of an increased CAR and an earlier peak. 
This has been accounted for by the observation that cortisol levels remained 
relatively unchanged over the first 5–10 min post-awakening (‘latent period’), with a 
significant increase first being detectable in the 15 min sample. These data suggest 
that moderate sampling delays shift the examined time window closer to the actual 
increase component by removing the latent period from the analysis, thus resulting in 
higher CAR estimates with an earlier peak component (Smyth et al., 2013, 2015). 
Figure 3b illustrates this notion for an exemplary 8 min sampling delay. 
Inaccuracy in the commencement of sampling immediately after awakening 
can arise from a range of scenarios, including non-adherence due to motivational 
reasons (avoidance of discomfort, attending to other responsibilities, etc.). However, 
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observations by Griefahn & Robens (2011) and Smyth et al. (2013) suggested that 
non-motivational factors might also influence awakening-related inaccuracies. In both 
studies, considerable sampling delays occurred for S1 even though participants took 
later samples in close accordance with the protocol. This suggests that delayed 
sampling after awakening may be the primary cause of inaccurate CAR assessment 
and arise in well-intentioned and otherwise conscientious participants (Smyth et al., 
2013). A potential explanation for this is the occurrence of sleep inertia in the 
immediate post-awakening period, i.e., a state of reduced cognitive and motor 
performance (Tassi and Muzet, 2000). Sleep inertia may increase the difficulty of 
adhering to requested timings and/or may impede the precise determination of the 
moment when one is fully awake (Clow et al., 2010; Smyth et al., 2013). 
In sum, recent evidence suggests that even well-intentioned participants may 
not always be able to precisely identify their awakening moment. This can lead to 
moderate delays in collecting S1 after awakening that are sufficient to substantially 
bias CAR estimates. In light of this, objective verification of awakening time is 
necessary for obtaining valid CAR data. 
3.2. Inaccurate post-awakening sampling
Besides failure to collect S1 immediately on awakening, inaccuracy may also arise 
from delays at subsequent sampling times. Table 1b summarizes data on the 
correspondence between self-reported and objectively verified times of saliva 
sampling in ambulatory CAR research. Two landmark studies focused on sampling 
accuracy during the post-awakening and the remaining diurnal sampling period 
(Broderick et al., 2004; Kudielka et al., 2003). Inaccurate saliva sampling occurred 
relatively frequently and was associated with an underestimation of the CAR. This 
general pattern was later confirmed by research specifically focusing on the CAR in 
adults (Kudielka et al., 2007b), in parents obtaining CAR samples of their preschool-
age children (Smith and Dougherty, 2014) and in a large multi-ethnic sample (Golden 
et al., 2014). An important qualitative extension of these data was provided by 
findings showing that the accuracy of saliva sampling can be considerably improved 
by informing participants about the fact that they are being objectively monitored 
(Broderick et al., 2004; Kudielka et al., 2003). The potential implications of this latter 
finding are discussed in detail in section 4.2.4.
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4. Strategies for dealing with inaccurate sampling
The following sections describe available objective monitoring strategies for 
ambulatory CAR research, discuss ways for dealing with identified inaccurate data 
and look into potential strategies in lieu of objective measures.
ISPNE CAR consensus
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4.1 Objective monitoring strategies
Accurate assessment of the CAR requires objective verification of awakening and 
sampling times (Adam and Kumari, 2009). Ideally, such objective methods should be 
employed in combination with a diary log system to record self-report data of 
awakening and sampling times (besides other factors, such as potential covariates; 
see 6.3). 
4.1.1 Methods for verifying awakening and sampling times
Several methods have been used to verify awakening times. Polysomnography 
(PSG) is considered the gold standard in sleep research (Van De Water et al., 2011) 
and has been used for verifying awakening times in CAR research (e.g., Gribbin et 
al., 2012; Griefahn & Robens, 2010, 2011; Okun et al., 2010). However, PSG is 
costly, labor-intensive and disruptive to participants’ normal routines (Van de Water 
et al., 2011). Wrist actigraphy might be a more readily obtainable method as it is 
minimally-disruptive, relatively inexpensive and well-validated against PSG for 
assessing sleep parameters (e.g., Cole et al., 1992; Lichstein et al., 2006). Wrist 
actigraphy has been successfully used in ambulatory CAR research across several 
studies (e.g., Smyth et al., 2013). Another actigraphy-based approach is the use of 
chest-worn motility monitors that additionally record heart inter-beat-interval (IBI) data 
(CAR research: Kupper et al., 2005; Stalder et al., 2011). As arousing from sleep is 
associated with an increase in heart rate (e.g., Huikuri et al., 1994) and rapid 
cardiovascular activation lasting around ten heart beats (Trinder et al., 2001, 2003), 
available IBI data (together with actigraphy data) could further help to more precisely 
determine the awakening moment. Still, each of the above described methods 
appears suitable for the verification of awakening time in CAR research. In addition, 
future research may explore the use of recently developed smartphone-linked or 
consumer-brand devices as potential low cost alternatives for objective awakening 
time verification (review: Kelly et al., 2012). However, this strongly rests on the 
successful validation of such devices against a well-established method, such as 
PSG, which to date is mostly still lacking (Kelly et al., 2012; Meltzer et al., 2015).
Concerning the verification of sampling times in ambulatory research, the 
commonly used electronic monitoring systems have proven useful. These typically 
use screw top bottles that record times of bottle openings, however, boxes that 
record time stamps have also been devised. By storing saliva sampling devices 
inside the bottle and instructing participants to restrict openings to the times of 
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sample taking, the respective time stamps provide an indirect index of sampling 
times. Clearly, the use of such systems cannot fully protect against intentional misuse 
(e.g., participants may still take out samples from the bottle without performing the 
saliva sampling) but it does present the current best practice. Alternatives to this 
approach might arise as a consequence of modern technology. For example, 
smartphones with built-in cameras could be used to obtain time-stamped self-
photographs (‘selfies’) by participants when collecting a sample to verify sampling 
accuracy in future studies. If adequately developed, such a strategy can equally be 
recommended for the verification of sampling accuracy as electronic monitoring 
systems. 
An alternative approach that removes the need for sampling time verification is 
the use of automated sampling methods to assess the CAR. For one, intravenous 
blood sampling, when coupled with stationary PSG assessment (e.g., Wilhelm et al., 
2007), ensures the accuracy of CAR assessment. However, as this research is 
typically restricted to the sleep laboratory, its artificial setting is associated with 
reduced ecological validity. This may be prevented by recently developed systems for 
automated sampling of subcutaneous tissue free cortisol (Bhake et al., 2013). 
Although clearly more demanding and invasive for participants than the self-collection 
of saliva samples, this approach could potentially allow the assessment of the CAR in 
participants’ home settings in some future research.
4.1.2 Dealing with verified inaccurate data
Once information on sampling accuracy has been obtained, it can be used to reduce 
bias on CAR estimates through (i) data exclusion strategies and (ii) statistical 
modeling approaches. 
For data exclusion strategies, the extent of inaccuracy is usually first 
calculated as the discrepancy between the scheduled and the actual/verified 
sampling time (Δt). The Δt-value of individual sampling times is then compared to a 
predetermined accuracy margin (e.g., 5, 10 or 15 min) and, in case any Δt exceeds 
this margin, CAR data for the respective sampling day are excluded from subsequent 
analyses (e.g., Kudielka et al., 2003). When using such an approach, deciding on the 
most suitable accuracy margin for data exclusion is difficult. Proceeding from the 
above reviewed findings (particularly: Smyth et al., 2013, 2015), even small time 
discrepancies may entail substantial bias on CAR estimates, unless they become 
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negligible (i.e., Δt ≈ 0 min). However, narrowing accuracy margins causes a growing 
loss of (putatively informative) data. Consequently, any consensus about a fixed 
accuracy margin is necessarily a trade-off between scientific precision and practical 
feasibility. For example, previous research employing awakening time verification by 
wrist actigraphy suggests that specifying an accuracy margin of Δt = 0 ± 5 min for S1 
will yield data loss of 26–46% (DeSantis et al., 2010; Dockray et al., 2008). In 
addition, the selective exclusion of participants with inaccurate sampling may result in 
potential selection bias and reduced generalizability of results. In order to keep the 
percentage of classified inaccurate data (and thus data loss and potential bias) as 
low as possible, it is crucial to employ a full range of measures to maximize 
adherence (see section 5). 
In the second group of strategies, verified inaccurate data are not excluded but 
instead the objective information on actual sampling times is utilized for the 
calculation of CAR estimates (i.e., these data are incorporated into the statistical 
model). Hence, this provides a more economical approach, preventing unwanted 
data and participant loss, and resulting concerns regarding reduced generalizability. 
To use such a strategy, statistical models are required that adequately describe the 
temporal dynamics of cortisol secretion across the CAR period. Section 7.4 provides 
a description of such modelling approaches in CAR research. 
In sum, the decision about the most adequate strategy involves trading off 
considerations about scientific precision against those of practical feasibility. 
Researchers’ primary concern should be to obtain valid, unbiased data. The use of a 
well-specified statistical model of the CAR that incorporates verified awakening and 
sampling time data fulfils this criterion and should be the method of choice. When 
using data exclusion strategies, achieving any confidence that CAR data are not 
biased requires the specification of relatively strict accuracy margins which, 
unfortunately, is associated with data loss. To achieve comparability between 
studies, we recommend that future research employs a transparent approach 
whereby it is clearly stated whether findings emerge when applying a strict accuracy 
margin of Δt = 0 ± 5 min for each post-awakening sample, either as the sole 
approach or in combination with researchers’ own analytical strategy (i.e., as an 
additional sensitivity analysis).  
4.2 Are there viable strategies without the use of objective measures?
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The use of objective monitoring strategies increases the costs per participant and 
may thus reduce the number of participants from whom endocrine data can be 
obtained (Adam and Kumari, 2009). This may lead researchers to consider whether 
alternative strategies exist that yield valid CAR data without having to employ 
objective measures. 
4.2.1 Forced awakening
A design-based strategy to counteract problems of sampling inaccuracy is to 
externally awaken participants (usually through study personnel). This is a work-
intensive approach that has been used with participants examined in a hospital 
setting (e.g., Huber et al., 2006; Nicolson and Van Diest, 2000), sleep laboratory 
(Wilhelm et al., 2007) or quarantined as part of a larger study (Polk et al., 2005). 
Recently, a variation of this approach has been employed in infants and young 
children who were too young to sample saliva themselves and were thus woken up 
by their parents to ensure the accuracy of sampling initiation (Bäumler et al., 2013, 
2014a, 2014b; Stalder et al., 2013). In the latter studies, this was further 
complemented by objective verification of awakening and sampling times. 
An argument in favor of a forced awakening approach is that current evidence 
suggests that the CAR is unaffected by participants’ mode of awakening 
(spontaneous vs. externally woken; e.g., by alarm clock; Stalder et al., 2009; Wüst et 
al., 2000b). This makes it unlikely that forced awakening leads to fundamentally 
different CAR profiles than spontaneous awakening. However, a remaining danger is 
that participants may wake up prior to the planned wake up time. Hence, a forced 
awakening approach should still be complemented by objective awakening time 
verification. Under such a condition, forced awakening may help to yield high quality 
CAR data, particularly if study personnel also continue to monitor the accuracy of 
subsequent saliva sampling. The latter possibility may then spare the use of 
electronic monitoring devices to verify sampling accuracy (see 4.2.1). 
Besides issues related to sample timing inaccuracy, however, researchers 
assessing the CAR in a hospital or sleep-laboratory setting need to be aware of the 
possibility of state-related confounding which can induce significant bias in CAR 
analyses (see 6.2). Further, as mentioned before, such conditions are associated 
with reduced ecological validity, which is a key advantage of sample collection in 
participants’ home settings. 
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4.2.2 Increasing statistical power
Researchers may wonder whether problems of sampling inaccuracy cannot be 
overcome by simply increasing statistical power, e.g., in large-scale epidemiological 
research. Indeed, this would be the case if inaccuracy occurred randomly, i.e., not 
systematically related to relevant participant characteristics (cross-sectional 
research) or situational factors (intra-individual research). Under such circumstances, 
inaccurate sampling would merely increase the error of CAR estimates, which could 
be tackled by increasing the number of observations. However, extensive data 
indicate that non-adherence, a factor which is likely to strongly affect sampling 
inaccuracy, does not occur randomly but covaries with relevant psychological factors. 
For example, research has shown that adherence to medical treatments regimens is 
influenced by individual differences in depressiveness and/or social support (meta-
analyses: DiMatteo, 2004; DiMatteo et al., 2000). Research focusing on the CAR also 
confirmed an inverse relationship between perceived social support and sampling 
inaccuracy (Kudielka et al., 2007b). In a large multi-ethnic study, inaccurate sampling 
of a diurnal cortisol profile (including post-awakening samples) was related to lower 
income, education levels, and (marginally) ethnicity (Golden et al., 2014). 
Furthermore, effects of sampling accuracy have been found to interact with health 
status, i.e., female fibromyalgia patients were less influenced by being informed 
about the use of objective monitoring strategies than healthy controls (Broderick et 
al., 2004). This indicates that inaccurate sampling is likely to co-vary with parameters 
that are of central interest to PNE inquiry, i.e., psychological or health-related factors. 
Under such circumstances, failing to control for sampling accuracy poses the eminent 
threat that true relationships may be obscured or false relationships may be 
accepted. In this case, “(i)ncreasing the N or the number of samples collected will 
yield the same level and direction of error. In fact, increasing statistical power would 
only increase the researcher’s confidence in a false result.” (Broderick et al., 2004, p. 
648). 
There is less evidence on state correlates of sampling inaccuracy from intra-
individual CAR research. Broderick et al. (2004) observed no differences in sampling 
accuracy between weekdays and weekends, a factor frequently associated with 
altered CAR profiles (Kunz-Ebrecht et al., 2004b; Schlotz et al., 2004). Still, it is 
clearly conceivable that inaccurate sampling may co-vary with state psychological 
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factors relevant for PNE research (e.g., state arousal or stress, prospective memory 
load, sleep characteristics; Law et al., 2013). Hence, it cannot be excluded that 
failure to objectively control for inaccurate sampling confounds intra-individual CAR 
data. Again, this problem cannot be alleviated by increasing statistical power. 
4.2.3 Exclusion of CAR non-responders
Inaccurate sampling has often been associated with flattened or even negative CAR 
profiles (e.g., Broderick et al., 2004; Dockray et al., 2008; Kupper et al., 2005). This 
has led to the proposition that issues of sampling inaccuracy may be addressed by 
excluding participants who fail to show a cortisol increase from S1 to later samples as 
these are ‘suspected non-adherents’ (Thorn et al., 2006). However, this is unlikely to 
be a sufficient approach. The effects of inaccurate sampling on CAR estimates are 
likely to be non-linear and continuous (see Figures 3b–d): compared to fully accurate 
sampling, small delays after awakening may first result in an overestimation of the 
CAR which then turns into the well-documented underestimation of the CAR with 
longer delays (>15–20 min). The complete absence of a post-awakening increase 
(i.e., a negative CAR) is likely to occur only if the delay between awakening and the 
initiation of sampling exceeds the peak of the underlying CAR (between 30–45 min, 
see Figure 3d). The exclusion of negative CAR profiles would thus eliminate only 
extreme cases of inaccurate sampling but not mild or moderate cases, which already 
have the potential to substantially bias results. 
In addition, the exclusion of CAR non-responders may by itself induce bias. It 
is still unresolved whether, given fully accurate sampling, there are genuine 
occurrences of participants not showing a positive CAR. Preliminary evidence 
suggests that this may indeed be the case: in accurately sampled data based on 
objective monitoring, no increase or only a minor CAR (<2.5 nmol/L, Wüst et al., 
2000b; or <1.5 nmol/L; Miller et al., 2013a) emerged on 13.1% of study days in 
infants (Stalder et al., 2012), on 18.0% of days in toddlers and young children 
(Bäumler et al., 2013), in adults on 14.7% (Dockray et al., 2008), and on 19.7% of 
days in healthy participants (Smyth et al., 2013). Of note, patients with brain lesions, 
particularly in the hippocampal formation (Buchanan et al., 2004; Wolf et al., 2005), 
appear to show more generally attenuated or even absent CARs (see also section 
6.3). Overall, these data indicate that absent CARs may represent genuine 
phenomena that simply form the lower end of a distribution of CAR magnitudes. 
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Following this assumption, absent CARs should occur more frequently within groups 
that as a whole exhibit a reduced CAR profile. CAR research often investigates group 
differences (e.g., between clinical patients and control subjects), thus by definition 
trying to prove that one group has a lower CAR than another. Hence, a CAR non-
responder exclusion strategy would bias data by systematically excluding a greater 
percentage of low values from one group than from another. 
4.2.4 Informational strategies
In research examining diurnal cortisol levels (including post-awakening sampling), 
participants who were informed about their sampling accuracy being verified by 
electronic monitoring systems showed a 76% reduction in cumulated sampling 
deviations compared to ‘non-informed’ participants (Kudielka et al., 2003) and more 
days with accurate sampling (informed: 90%, non-informed: 71%; Broderick et al., 
2004). Importantly, besides improving the actual rates of sampling accuracy, 
‘informed’ participants also tended to correctly self-report their sampling times, even if 
they had not sampled accurately (Broderick et al., 2004; Kudielka et al., 2003). 
Subsequent research with participants being informed about objective monitoring 
mostly confirmed high accuracy of post-awakening sampling in these individuals 
(Griefahn and Robens, 2011; Smyth et al., 2013) although this was not the case in a 
recent study on a large multi-ethnic sample (see Table 1b; Golden et al., 2014).
Still, the above data may indicate the possibility that merely informing 
participants about the use of objective control methods could provide a strategy for 
obtaining reliable data on sampling accuracy (i.e., through self-reports). In this 
context, ‘mock’ strategies could be considered, with participants being told that 
objective monitoring strategies are being used without this actually being the case. 
Besides ethical considerations, it is important to note that the efficacy of such an 
approach has not been tested yet. This is not trivial as the effectiveness of a mock 
compared to a real ‘informed’ strategy may be reduced by several routes, such as 
non-verbal transmission of lower expectations from experimenters to participants 
(given experimenters’ awareness that no objective monitoring is being used) or 
passing on of information about the non-functionality of objective monitoring between 
participants (e.g., in student populations). A potential solution may be an ‘open’ 
strategy as part of which objective monitoring is employed in a random subgroup, 
while all participants are told that there is a chance of being monitored (Adam and 
Kumari, 2009). While this avoids deceiving participants, it is unclear whether 
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information about the mere chance of being monitored is equally effective as 
certainty about this fact. Hence, without firm evidence showing the effectiveness of 
such an approach, it is recommended that objective monitoring is employed across 
all participants and is not substituted with an informational strategy. Notwithstanding, 
evidence clearly suggests that participants should always be informed about the use 
of objective monitoring strategies. 
5. Maximizing adherence
Irrespective of objective monitoring, it is expedient to work towards maximizing 
participant adherence. Such strategies are cost-efficient as they prevent data loss 
through the exclusion of inaccurately sampled data and increase data quality (i.e., 
fully adherent data are superior to statistically inferred/corrected data). Table 2 lists 
strategies for maximizing adherence in CAR research. Several of these strategies are 
derived from the authors’ collective research experience, without formal published 
evidence on effectiveness testing. 
An important opportunity for increasing participant adherence is provided by 
the initial face-to-face meeting. Strategies employed during this meeting may both 
raise participants’ motivation for being adherent and help to increase the clarity of the 
study procedure. An important way to raise motivation is trying to engage participants 
with the research goals. Besides conveying the general purpose of the study, this 
involves explaining the importance of being adherent in CAR research and the 
consequences of non-adherence. To ensure that participants fully understand the 
whole study procedure, it is considered important that researchers go through the 
protocol in detail with them and practice relevant components (e.g., the saliva 
sampling procedure). As part of this, it should be explained precisely what is meant 
by the ‘moment of awakening’ in order to standardize this critical aspect across 
participants (Adam & Kumari, 2009). We recommend that such a definition should 
focus on the regaining of consciousness as the central characteristic of the 
awakening moment (e.g., “When you are awake, i.e., you are conscious: you know 
who and where you are; you are in a state that is clearly different from when you 
were sleeping even though you may still feel tired.”). In addition, it should be made 
clear that participants should not initiate sampling after premature nightly awakenings 
(e.g., “If you wake during the middle of the night and plan to go back to sleep, do not 
begin sampling; please only begin when you are awake for the final time before you 
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plan to get up for the day.”) and that they should refrain from dozing or snoozing 
during the CAR sampling period (e.g., “During this study, please do not fall back to 
sleep or ‘doze’ after your initial awakening. You can stay in bed or get out of bed but 
please stay awake (even if you are not fully alert) during and after the saliva sampling 
period.”). Besides using the initial face-to-face meeting to clarify such critical 
questions about sample timing, it is also important that appropriate sampling dates 
are negotiated by the researcher and participant and agreed as 'convenient and 
typical'.
Besides face-to-face contact, take-home instructions in written form should be 
provided. For some populations, the additional use of instructional DVDs has proven 
useful (e.g., Stalder et al., 2013). Overall, it is important to make instructions as 
explicit and practice-orientated as possible, e.g., participants may be told to place the 
sample kit and a pen beside the bed before going to sleep to avoid post-awakening 
delays through having to search for the material (Adam and Kumari, 2009). 
Strategies that make the collection kit more user friendly and help participants 
organize the collection (e.g., color coding of material) are also deemed helpful. 
Researchers have further had positive experiences with using reminder phone calls, 
emails, or text messages on the evening prior to sampling (e.g., Smyth et al., 2013). 
Besides reminding participants of important procedures (e.g., to wear actigraphy 
devices to bed), such measures also signal an extra effort made by the research 
team, thus again highlighting the importance of accurately following the study 
procedure to participants. In addition, recent studies have employed methods for 
reminding participants about times of post-awakening sample collection. These 
include automated strategies, e.g., reminder watches (Franz et al., 2013), reminding 
through participants’ mobile phones (Garcia-Banda et al., 2014) or electronic 
reminders, e.g., timers that are activated by participants when taking S1 and then 
beep/flash at the later sampling times (e.g., Doane and Adam, 2010; Griefahn and 
Robens, 2011). In addition, reminder phone calls or text messaging at participants’ 
individually predicted sampling times has been employed (e.g., Oskis et al., 2009). 
While such strategies may increase adherence by preventing against the forgetting of 
sampling, they cannot provide certainty about the accuracy of sampling. Hence, they 
should only be viewed as complementary approaches but cannot replace objective 
monitoring strategies.
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[Please insert Table 2 about here]
6. Dealing with covariates
Researchers have to deal with the fact that hormone secretion is related to a large 
number of state and trait factors (Schlotz, 2011). Depending on the research context, 
these covarying factors may be considered confounders, mediators, moderators or 
direct variables of interest (Adam and Kumari, 2009; Kudielka et al., 2012; Schlotz, 
2011). If a covariate is not of main interest, the most critical question is whether it 
confounds observed associations (Schlotz, 2011). Confounding is given when a 
covariate is related to both the CAR and the variable(s) of interest, thus creating a 
spurious relationship between them, and needs to be addressed. However, even if a 
factor is only related to the CAR but not to other variables of interest, this may 
increase the error variance of the model and thus reduce statistical power for 
detecting associations with the CAR (Schlotz, 2011). Strategies for preventing 
unwanted influences of covariates in ambulatory PNE research can be grouped into 
instructional, statistical adjustment and exclusion strategies (Kudielka et al., 2012; 
Schlotz, 2011). 
6.1 Instructions about post-awakening behavior
Besides informing participants about the necessity to collect samples in close 
accordance with the specified sampling times (sections 3–5), further instructions may 
address participant behavior over the post-awakening period. Table 3 provides an 
overview of factors to be considered in this context. The most common instructions 
have been for participants to take nil by mouth other than water, refrain from smoking 
and omit cleaning their teeth (to avoid abrasion and vascular leakage into saliva) until 
after the final sampling (Clow et al., 2004). There is support for an influence of the 
first two factors: Cortisol secretion is known to be acutely influenced by caffeine and 
nicotine intake (review: Kudielka et al., 2009), food consumption (particularly high 
protein foods; e.g., Gibson et al., 1999; Rosmond et al., 2000) and blood glucose 
levels (Rohleder and Kirschbaum, 2007). This suggests that breakfasting (incl. 
caffeinated or sugared drinks and/or protein-rich foods (e.g., eggs) or smoking during 
the post-awakening phase may affect the CAR. By contrast, tooth brushing is at least 
unlikely to be associated with strong group effects as salivary cortisol levels were 
found to be unaffected by normal dental hygiene (Gröschl et al., 2001) or even 
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vigorous tooth brushing, despite the latter leading to blood leakage into saliva 
(Kivlighan et al., 2004). Research in children, using salivary transferrin levels as a 
marker of blood contamination, also concurred with the general notion that blood 
contamination through dental hygiene is unlikely to have a strong effect on salivary 
cortisol levels (Granger et al., 2007). 
Similarly, current findings speak against an influence of physical 
behavior/activity levels in the normal range on the CAR, which has been found to be 
unaffected by postural changes (i.e., remaining supine vs. standing/behaving 
normally; Hucklebridge et al., 2002; Wilhelm et al., 2007) or the level of motility over 
the post-awakening period (Stalder et al., 2009). However, this does not apply to 
physical exercising, which is known to induce cortisol reactivity when performed 
above a certain intensity level (e.g., Hill et al., 2008; Kirschbaum and Hellhammer, 
1994). Finally, participants’ mode of awakening (spontaneous vs. alarm clock) has 
been found unrelated to expression of the CAR (Stalder et al., 2009; Wüst et al., 
2000b). Still, as the above studies did not control for the beta error, it cannot be 
excluded that small effects exist but were not detected in the respective study 
samples. 
Together, an effect on the CAR is particularly suggested for eating, drinking 
(caffeinated or sugared beverages), smoking or engaging in physical exercise during 
the post-awakening period. Concerning these behaviors, in most research contexts it 
is recommended that researchers (i) instruct participants to abstain from these 
behaviors until after they have finished post-awakening sampling. Alternatively, (ii) in 
case researchers feel that these restrictions impose a too severe burden on 
participants’ normal routines (i.e., reducing willingness to participate and/or ecological 
validity), participants may be allowed to engage in these behaviors but should then 
be strongly encouraged to report this systematically (e.g., through the diary log 
system). This is critical to facilitate subsequent statistical adjustment for such 
potential influences. The latter point also applies to those behaviors without a proven 
influence on the CAR (mode of awakening, dental hygiene, moderate physical 
activity), for which it is still recommended to obtain self-report data. Furthermore, in 
instances when participants are allowed to eat, drink and/or brush their teeth, they 
should be instructed to rinse their mouth afterwards and to abstain from engaging in 
these behaviors in the immediate period (1–2 min) before sampling.  
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[Please insert Table 3 about here]
6.2 Control variables
There are several covariates of the CAR that cannot be influenced by instructions. 
These include factors that are difficult to standardize in ambulatory settings (e.g., 
ambient light levels), natural circumstance (e.g., season, menstrual cycle phase) or 
dispositional factors (e.g., age, sex). Table 4 shows the most important of these 
covariates. These are usually dealt with through statistical adjustment or by matching 
of study groups accordingly. For the sake of conciseness, the following part does not 
go into detail on between-study inconsistencies in results but focuses on practical 
implications for the main parameters. Also, for the ease of reading, references are 
only provided in the table but not in the text. For in-depth discussions of CAR 
covariates interested readers are referred to the respective review articles (state 
factors: Law et al., 2013; trait factors: Fries et al., 2009; Chida & Steptoe, 2009; 
sleep-related: Elder et al., 2014). Importantly, many of these data are based on CAR 
assessments without objective monitoring strategies. Hence, it cannot be excluded 
that previously discussed issues of inaccurate sampling might have biased these 
findings. 
6.2.1 State covariates 
Expression of the CAR on a particular day is to a large part determined by state-
related factors (Almeida et al., 2009; Hellhammer et al., 2007; Stalder et al., 2010b; 
see also 7.2). These are often variables of interest in CAR research. When state 
variables are not the central focus, they should nonetheless be measured and 
covaried. Table 4a shows the most important state covariates of the CAR and 
provides selected citations. Sleep-related factors comprise an important group, with 
time of awakening being particularly important (earlier awakening generally being 
associated with an elevated CAR). Although evidence on other sleep characteristics, 
e.g., sleep duration or quality, is still emerging and is less consistent, it is still 
recommended that they should be captured as potential covariates. Conversely, 
mildly disturbed sleep or sleep restrictions appear to have little effect on the CAR 
while an influence of sleep architecture is presently unclear (Elder et al., 2014). Some 
high-quality data for the assessment of sleep-related factors in CAR research may 
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conveniently be derived from the employed methods of objective awakening time 
verification (actigraphy or polysomnography; see 4.2.1) and should be reported. 
Higher levels of ambient light have been related to an elevated CAR. Objective 
assessment of light levels would be ideal (e.g., through small and unobtrusive 
photosensor devices; Figueiro et al., 2012), but may not be feasible for many CAR 
studies. Obtaining self-report data on participants’ retinal light exposure (lighting of 
the bedroom, use of eye masks, etc.) provides an alternative strategy in this context. 
Further, in non-ambulatory studies (e.g., sleep laboratory), light exposure should be 
kept at constant levels (Elder et al., 2014). The season of assessment may also 
affect CAR expression (data are inconsistent) and should be considered as a 
covariate in studies conducted over extended time periods. 
Psychosocial factors surrounding the sampling day comprise an important 
group of state covariates. The CAR seems to be affected by experiences over the 
day prior to CAR sampling, with a larger CAR being found after days characterized 
by more negative feelings (e.g., threat, lack of control or loneliness). On the study 
day, anticipations of a more demanding or challenging day ahead have been related 
to an increased CAR. This entails evidence showing a larger CAR on weekdays vs. 
weekend days, on days with more naturally occurring anticipated 
challenges/obligations and on days with experimentally induced higher prospective 
memory load in children and social challenge in adults. Overall, these data concur 
with the hypothesis that the CAR serves a function in preparing the individual for 
challenges of the upcoming day, which may be modulated by post-awakening 
anticipatory processes (Adam et al., 2006; Fries et al., 2009; Wilhelm et al., 2007). 
Thus, state psychosocial factors surrounding the study day should be assessed (e.g., 
by using a diary log system) and their influence on results examined and, potentially, 
adjusted for. 
It is important to emphasize that adequate addressing of state covariates is 
also important for cross-sectional studies. Indeed, any systematic relationship 
between state covariates and examined individual-level variables (sociodemographic 
features, clinical patient status, psychosocial stress levels, etc.) can lead to 
confounding (Adam and Kumari, 2009; Hellhammer et al., 2007). The danger of such 
state-related confounding is particularly evident for the above-discussed psychosocial 
parameters (Stalder et al., 2010a, 2010b). For example, despite being matched 
carefully on sociodemographic grounds, studied groups are often examined under 
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different state circumstances, e.g., hospitalized patients vs. home-based controls 
(Gaab et al., 2005) or largely non-working patients vs. working controls (Roberts et 
al., 2004). Such situational differences may covary with state psychosocial factors, 
such as prospective memory requirements, i.e., less planning might be required for a 
hospital day compared to a work day (Stalder et al., 2010a). Under such 
circumstances, group differences in CAR profiles could be falsely attributed to 
participants’ clinical status when they are indeed due to the differential assessment 
contexts. Hence, clear awareness of the possibility of state-related confounding 
should guide researchers’ study planning. This may include the assessment of state 
covariates as well as design-based choices, e.g., in the above example, researchers 
may choose to recruit a hospital-based control group or to postpone the assessment 
of clinical patients until they have left the hospital setting. 
[Please insert Table 4 about here]
6.2.2 Trait covariates
Several sociodemographic and health-related parameters have been identified as 
trait covariates of the CAR (see Table 4b). Although data are characterized by 
inconsistency and the magnitude of effects is generally small, it is still recommended 
that these factors be considered as potential confounds. A relatively consistent 
finding is an influence of sex; with women exhibiting a larger and more prolonged 
CAR than men. Age effects on the CAR have also been reported by some research, 
mainly occurring during specific developmental stages, such as infancy/early 
childhood, the onset of menarche in female adolescents and with aging. Other 
potentially relevant factors that have been related to the CAR are ethnicity and/or 
socioeconomic status as well as health-related behaviors, such as habitual smoking 
and heavy drinking. Furthermore, information on body fat-related anthropometric 
measures (body-mass-index or waist-to-hip ratio) and, in women, the use of oral 
contraceptives should be obtained and considered as covariates. 
6.3 Exclusion criteria
The impact of some covariates is considered so severe that elimination of affected 
data from analyses seems necessary, i.e., by excluding participants or by postponing 
CAR sampling until the covariate is no longer present. Table 5 lists variables that 
may be considered as exclusion criteria in CAR research. Concerning acute factors 
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on the testing day, it is sensible that CAR sampling is postponed for participants with 
an active illness (e.g., influenza, common cold) until they are in a healthy state again 
(Adam, 2006; Adam and Kumari, 2009). Likewise, sampling should be rescheduled in 
participants under the acute influence of major circadian rhythm changes, e.g., shift 
work or jet lag (shift work: Federenko et al., 2004; Griefahn and Robens, 2010; Harris 
et al., 2010; Kudielka et al., 2007a; jet lag: Doane et al., 2010), to a time when they 
have slept at least seven nights under a constant day-night schedule.
Another potentially important factor is the female menstrual cycle. One study 
has reported differences in the CAR during the short period of ovulation (Wolfram et 
al., 2011) but not between the follicular and luteal phase (Kudielka and Kirschbaum, 
2003). While CAR sampling during the ovulatory period should thus ideally be 
avoided, regular incorporation of objective methods (hormonal assays or ambulatory 
chromatographic tests) into CAR research is not always going to be feasible. Thus, 
researchers may estimate the time of ovulation based on self-report data (i.e., 
midway through the usual menstrual cycle length) and avoid sampling around this 
time (e.g., ± 2 days), thus accounting for inter-cycle and inter-individual variability. 
Alternatively, with sufficiently large sample sizes, menstrual timing may be measured 
and its influence on CAR estimates statistically accounted for. 
Concerning longer-term influences, the use of oral glucocorticoid (GC) 
medication is a frequent exclusion criterion in salivary cortisol research (review: 
Adam and Kumari, 2009; Granger et al., 2009). Exogenous GCs are likely to affect 
HPA axis activity through negative feedback induction (Granger et al., 2009) and, 
when administered orally, may induce false-high values by cross-reacting with 
antibodies in the immunoassay (e.g., Perogamvros et al., 2010). Although direct 
evidence on the CAR is still outstanding, systemic GC administration resulted in 
marked attenuation of salivary cortisol levels 30 min post-awakening (Masharani et 
al., 2005) and should thus be an exclusion criterion in most research circumstances. 
Other types of medication may also influence salivary cortisol levels via direct and 
indirect pathways (review: Granger et al., 2009). Medication intake should thus be 
assessed and decisions about participant inclusion/exclusion be made after case-by-
case evaluation.
The presence of HPA axis-related endocrine disorders (e.g., Morbus Cushing, 
Morbus Addison) is another obvious exclusion criterion in cortisol research (Adam 
and Kumari, 2009). Concordantly, suffering from active Cushing’s disease has been 
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associated with an attenuated CAR (Roa et al., 2013). A detailed discussion of other 
endocrine disorders is beyond the scope of this article and a case-by-case evaluation 
should guide the inclusion/exclusion of endocrine patients. Furthermore, there is 
converging evidence that brain damage, particularly in the hippocampal formation 
(Buchanan et al., 2004; Wolf et al., 2005), is associated with marked attenuation or 
absence of the CAR and thus warrants participant exclusion. Likewise, particularly 
late pregnancy is associated with marked basal hypercortisolemia (De Weerth and 
Buitelaar, 2005), with at least some notion of attenuation of the CAR (Buss et al., 
2009). However, given the profound biological and psychological changes that occur 
throughout pregnancy, CAR profiles of pregnant women should generally not be 
compared to those of non-pregnant women. 
Finally, there is also abundant data revealing associations between the CAR 
and a range of mental and physical health conditions. A review of this literature is 
beyond the scope of this article and interested readers are referred to the respective 
review articles (psychosocial factors: Chida and Steptoe, 2009; health-reated factors: 
Kudielka et al., 2012). 
[Please insert Table 5 about here]
7. Procedural and design considerations
7.1 Sampling times
Figure 1b shows that the number of post-awakening samples has varied widely 
between CAR studies. While basic CAR research, which is usually conducted on 
smaller samples, has tended to employ protocols with 4–5 post-awakening samples 
(e.g., Edwards et al., 2001b; Pruessner et al., 1997; Wüst et al., 2000b), large-scale 
epidemiological research often only uses two sampling times (typically on awakening 
and 30–45 min post-awakening; Adam and Kumari, 2009). The choice about the 
number of sampling times involves a cost/accuracy trade-off: collection and assay 
costs increase with number of samples but a larger number of post-awakening 
samples also allows for more accurate estimation of CAR profiles. 
An important consideration concerning protocols with only two post-awakening 
samples is that, although they provide a general approximation of the underlying 
CAR, they cannot be sure to capture the CAR peak. Specifically, as the CAR usually 
peaks between 30 and 45 min post-awakening (Clow et al., 2004; Smyth et al., 2015; 
Wüst et al., 2000b), repeated sampling over this period is necessary to capture peak 
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levels. The resultant issues surrounding the use of two-sample protocols are not 
trivial: such protocols assume that the second sample (e.g., 30 min) will be taken 
near the peak of most individuals, with some random error in peak timing. 
Importantly, there is evidence that individual CAR peak times may not be randomly 
distributed but may itself be related to individual difference variables that can be at 
the focus of PNE research (e.g., Lopez-Duran et al., 2014). Specifically, systematic 
differences in CAR peak timing have been related to executive function (Evans et al., 
2012), adolescent development (Oskis et al., 2009), menstrual cycle phase/ovulation 
(Wolfram et al., 2011) and, at least descriptively, sex (Pruessner et al., 1997; Schlotz 
et al., 2004; Wüst et al., 2000b). Given such associations, two-sample protocols may 
lead to erroneous conclusions that a study variable is associated with the CAR 
magnitude whereas, indeed, it is associated with CAR peak timing. 
As knowledge on the main correlates of CAR peak timing is still limited, the 
use of two-sample protocols cannot be recommended. In case of financial 
restrictions, we suggest that CAR research on adult populations employs a protocol 
with a minimum of three sampling points: on awakening, 30 min and 45 min. This is 
considered a compromise combining relatively low costs with still sufficiently detailed 
information. Specifically, the chosen sampling points are likely to capture mean peak 
concentrations of both male (~30 min) and female (~45 min) adult populations (e.g., 
Pruessner et al., 1997; Schlotz et al., 2004; Wüst et al., 2000b). An exception to this 
guideline applies to research in children and pre-pubertal adolescents who may not 
yet exhibit sex-specific CAR patterns (e.g., Oskis et al., 2009). Hence, in such 
research the use of a two-sample protocol (0 and 30 min) may be justifiable. Still, 
researchers need to be aware that their data may be difficult to interpret as it remains 
unknown whether potential relationships are seen with CAR magnitude or differential 
CAR peak timing.
Overall, researchers aiming to conduct more fundamental CAR research are 
recommended to use a 4–5 sample protocol (e.g., 0, 15, 30, 45, 60 min) providing 
more in-depth information on temporal dynamics of post-awakening cortisol 
secretion. Notwithstanding, additional research on the impact of various sampling 
protocols (different sampling times) on the accuracy of CAR measurement is 
recommended. 
7.2 Number of study days (cross-sectional research)
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Initial findings on the CAR suggested moderate to high test-retest stability across 
repeated assessment days (e.g., Edwards et al., 2001b; Wüst et al., 2000b). These 
data were influential in recommending the CAR (measured on one or two days only) 
as a reliable trait biomarker. This is illustrated by the fact that 31.7% of recent studies 
obtained CAR measures on only one day while 47.1% of studies measured the CAR 
across two days (see Figure 1b). However, over the past decade, evidence has 
accumulated suggesting that earlier conceptions over-emphasized trait-specificity, as 
the CAR is prone to substantial intra-individual variability: Hellhammer et al. (2007) 
employed structural equation modeling to CAR data obtained across six consecutive 
days per person. Their results showed that the CAR on a single day is determined to 
a larger extent by situational factors (61–82%) than by longer-term, trait-like 
components (15–37%; Hellhammer et al., 2007). These findings were confirmed by 
subsequent research providing comparable state-specificity estimates of 78% 
(Almeida et al., 2009) and 64% (Stalder et al., 2010b). It was estimated that 
assessments on at least six days per person may be necessary for achieving reliable 
trait data on the CAR (AUCI; Hellhammer et al., 2007).
Concerning practical implications, it should be noted that reduced trait-
specificity per se does not constitute a serious problem for cross-sectional research. 
Indeed, if state influences occur randomly this will merely increase the measurement 
error, which can be counteracted by increasing the sample size. Unfortunately, it was 
shown that the assumption of truly random state variability is easily violated (see 
6.2.1). This possibility of state-related confounding poses the main threat to the 
integrity of CAR results. Importantly, extending the sampling period (e.g., to six or 
more days) does not necessarily protect against this danger. For example, in a 
scenario where confounding is related to systematic differences in the examination 
context (e.g., hospitalized patients compared to home-based controls), extending the 
sampling period will not solve the problem, unless the context is changed. Indeed, 
extending the sampling period may only yield a more reliable estimation of the 
influence of examination context. Hence, when trait CAR estimates are of interest, 
accounting for the possibility of state-related confounding on the CAR should be of 
highest priority (see 6.2). If this is adequately addressed, a flexible decision about the 
number of study days can be made, considering feasibility and power calculations 
(Adam and Kumari, 2009). Researchers should know, however, that, given only 
modest test-retest reliability of CAR assessments, the detectable effect sizes for 
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associations with trait measures are severely restricted for single-day CAR data and 
will increase with each additional day from which trait estimates are derived (e.g., 
Frost and Thompson, 2000). Hence, if practically feasible, it is recommended that 
CAR data are obtained over two or more sampling days. Given the importance of 
weekday-weekend differences in the CAR (see 6.2), we recommend that days be 
evenly distributed across the week (e.g., sampling on two weekdays and one 
weekend day) in cross-sectional research. 
7.3 Sample storage and cortisol analysis
Measurement of the CAR in ambulatory settings has been facilitated by the possibility 
to assess free cortisol levels using convenient saliva sampling (Hellhammer et al., 
2009; Kirschbaum and Hellhammer, 1989, 1994). A general review of salivary cortisol 
assessment methods is beyond the scope of this text and can be found in the 
following reviews (Hellhammer et al., 2009; Kudielka et al., 2012). 
Given that the CAR is often assessed in ambulatory settings, the storage of 
samples after collection is an important topic. Research suggests that salivary 
cortisol is relatively stable at room temperature for only a short time period (< 5 days) 
after which concentrations begin to decline (e.g., Clements and Richard Parker, 
1998; Gröschl et al., 2001; Whembolua et al., 2006). It is thus recommended that 
participants be instructed to place saliva samples in their home freezer immediately 
after data collection (i.e., every morning) and to return them to the lab as soon as 
possible. For this, transport of samples under cooled conditions is preferable, 
although potential effects of short-term thawing during transport are likely to be small; 
e.g., effects on cortisol levels have been observed after five, but not after two thawing 
cycles (Gröschl et al., 2001). 
Long-term storage of saliva samples should be at temperatures of –20°C or 
lower. Importantly, even with storage at –20°C, salivary cortisol levels have been 
found to decline over a period of nine months (Kudielka et al., 2012). These data 
suggest that particularly in longitudinal CAR research with collection periods 
stretched out across several years, researchers should strive for a prompt analysis of 
samples (ideally, within 0–6 months of sample collection).
Concerning the measurement of salivary cortisol concentrations, most 
analyses are performed by immunoassays. These are fast, relatively cheap and can 
be performed by most biochemical laboratories. Although cross-reactivity with other 
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analytes cannot be excluded, salivary cortisol immunoassays are generally deemed 
valid procedures and should thus be sufficient for assessing the CAR in most 
contexts. Concerning data interpretation, it should be known that immunoassays tend 
to overestimate cortisol levels in saliva (Jönsson et al., 2003) with substantial 
differences between assays (Kirschbaum and Hellhammer, 1989; Miller et al., 
2013b). More accurate information on salivary cortisol levels may be obtained by use 
of chromatography-based methods (e.g., Gao et al., 2015). However, these are more 
work-intensive and expensive and are thus only indicated when the assessment of 
additional analytes is of interest (e.g., salivary cortisone; Perogamvros et al., 2010).  
7.4 Statistical considerations
Prior to conducting inferential statistics on CAR data, cortisol values should be 
screened for distributional properties and outliers as a first step (see Schlotz, 2011). 
Such preprocessing procedures need to account for the fact that salivary cortisol data 
are usually positively skewed. To enable the use of general linear model-based 
analyses, it is thus recommended that appropriate transformation techniques are 
applied to approximate a normal distribution (Miller and Plessow, 2013; Schlotz, 
2011). Besides distributional properties, some extreme outlying cortisol values may 
be present which, if unaccounted for, would disproportionately influence the results of 
parametric statistics (Schlotz, 2011). A useful convention for this purpose is to define 
such outliers as log-transformed values that are located more than three standard 
deviations from the mean. Such values may be dealt with by excluding these subjects 
or observations from analyses (trimming) or by replacing them with the values of a 
preset margin, e.g., the upper or lower 5% percentiles (winsorizing; Schlotz, 2011).
Following adequate preprocessing procedures, inferential statistics can be 
applied to CAR data. If the purpose of such analyses is to investigate group 
differences in cortisol profiles, a rather straightforward approach is the use of simple 
repeated-measures analysis of variance (rANOVA). Here, a main effect of time is 
usually considered as evidence for the presence of a significant CAR, whereas time-
by-group interactions are examined for investigating group differences in CAR 
profiles. In addition, researchers are often interested in investigating continuous 
associations with the CAR which requires a single estimate of the CAR (to be 
included in regression-type models). For this purpose, CAR summary indicators are 
often computed, such as AUC-based measures, means or change scores 
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(Fekedulegn et al., 2007). Although a large number of such summary indicators can 
be applied to reactive cortisol data, these measures tend to be highly interrelated and 
have been shown to represent two main underlying components, i.e., ‘total cortisol 
production’ and ‘change in cortisol levels’ (Khoury et al., 2015). As explicated above 
(see section 2.2), only measures of the latter group, capturing the dynamic of post-
awakening cortisol changes (e.g., AUCI, mean increase, baseline-to-peak increase), 
should be referred to as measures of the CAR. In addition, besides such CAR-
summary indicators, results for the first sample on awakening (S1) should be 
reported (Clow et al., 2010; see section 2.2). Furthermore, given the inverse 
relationship between S1 and the CAR, exploratory analyses on the CAR may be 
conducted with the level of S1 being statistically adjusted for.
A weakness of the above approaches (rANOVA, summary indicators) is that 
they suffer from case-wise data exclusion (i.e., data of whole study days need to be 
discarded if a single data point is missing). Concerning the CAR, this problem is 
further aggravated by the common use of exclusion strategies for dealing with 
inaccurately sampled data (see section 4.1.2). The use of multiple imputation 
strategies comprises a possibility for dealing with data that is missing-at-random (see 
Schafer and Graham, 2002). Another, more convenient method for addressing such 
problems is the use of hierarchical (also known as mixed-effects or multilevel) 
regression modeling (see Raudenbush and Bryk, 2002, for a general introduction). 
Hierarchical regression models are also capable of accounting for the continuous 
dynamics of time (so called growth curves; Llabre et al., 2004) and thus provide more 
flexibility in handling inaccurately sampled data or missing values. In addition, 
hierarchical models can adequately deal with manifest problems of heteroscedasticity 
and auto-correlations in the error structure of cortisol data (see also Kudielka et al., 
2012) and allow for the simultaneous processing of between- and within-individual 
information (e.g., Hruschka et al., 2005). Furthermore, hierarchical regression models 
are flexibly extendible to account for different phases of cortisol secretion and/or 
varying cortisol peaks (piecewise growth curve models; Lopez-Duran et al., 2014; 
Schlotz et al., 2011; Willoughby et al., 2007), as well as for qualitative differences in 
cortisol secretion patterns, like non-responses to awakening (growth mixture models; 
Miller et al., 2013b).
8. Summary and guidelines
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The present review shows that in order to derive meaningful data from CAR 
research, attention needs to be paid to methodological detail to prevent the danger of 
obtaining biased results. The variant methodological standards employed in past 
research (see Figure 1b) are thus likely to have contributed to the inconsistency 
observed in this field. Hence, it is strongly recommended that researchers follow the 
guidelines described here for obtaining valid CAR data in future research. 
Table 6 summarizes the derived consensus guidelines. The control of sample 
timing accuracy takes up a chief position within this realm. Importantly, the reviewed 
data provides a strong case for recommending that future research should always 
employ objective strategies for the verification of awakening and sampling times to 
obtain valid data, even if that means testing fewer participants because of the 
increased per-subject costs. Further, alternative strategies that may reduce costs in 
future research are provided (e.g., use of time-stamped self-photographs to monitor 
sampling accuracy; see 4.1.1). Finally, if cost considerations preclude using objective 
monitoring across a whole cohort, the restriction of endocrine assessments to a 
random subsample of participants provides a valuable alternative (Adam and Kumari, 
2009). In parallel, when aiming to reduce costs in large-scale research, compromises 
in other procedural aspects (e.g., the number of post-awakening samples or 
assessment days) are likely to have less detrimental implications for the validity of 
results than cutting down monitoring standards (see 7.2). Besides objective 
monitoring, we also recommend the complementary use of diary log systems to 
derive subjective reference values against which to compare objective data. Such 
diary log systems should also provide a place for reporting any atypical events or 
violations with instructions. 
[Please insert Table 6 about here]
On-site strategies, such as forced-awakening and/or the monitoring of sampling by 
study personnel, can be useful if participants are examined in a stationary setting 
(e.g., hospital, sleep laboratory). However, while on-site monitoring of saliva sampling 
can substitute the use of electronic monitoring bottles, forced awaking cannot replace 
objective awakening time verification as participants may still wake up prior to the 
external wake-up time (see 4.1.1). Further, we do not recommend the exclusion of 
participants on the basis of their cortisol data (i.e., CAR non-responders) as this is 
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likely an insufficient strategy which, contrarily, may even in itself induce bias (see 
4.1.3). For that matter, strategies for dealing with inaccurate sampling have to be 
rooted in the use of objective monitoring strategies. Two general approaches can be 
applied involving either the exclusion of data outside a predetermined accuracy 
margin or the use of statistical modeling techniques to incorporate objectively verified 
time data. Although researchers may choose their individually preferred approach, to 
achieve some level of consistency and comparability between studies, we 
recommend that results of (additional) sensitivity analyses are provided with CAR 
data being excluded on the basis of a strict accuracy margin of Δt = 0 ± 5 min for 
each post-awakening sample. 
Evidence clearly suggests that participants should be informed about the use 
of objective monitoring devices as this improves adherence (note: this should not be 
used as a substitute for actual objective monitoring). Furthermore, other strategies 
have been outlined based on researchers’ collective experience that may maximize 
adherence by positively affecting participant motivation and/or improving the clarity of 
the assessment procedure (see 5). Instructing participants should also be used as a 
first step towards limiting the influence of covariates on the CAR. This particularly 
concerns instructing participants to refrain from eating or drinking (except for water), 
smoking and exercising during the morning sampling period. Conversely, current 
evidence does not indicate that participants need to abstain from tooth brushing or 
have to be instructed concerning their mode of awakening or post-awakening activity 
level (see 6.1 and Table 3). Notwithstanding, participants should always be 
encouraged to report engaging in any such post-awakening behaviors which may 
then be considered as potential confounds.
 Adequate assessment of state and trait covariates of the CAR is crucial for 
preventing the possibility of confounding. Practical guidelines for dealing with the 
most important such covariates have been provided (see 6.2 & 6.3). An often 
underestimated danger is state-related confounding in cross-sectional CAR research. 
Researchers should consider whether systematic differences exist in the examination 
context of participants and adjust for this possibility in their study planning (see 6.2). 
In addition, the effects of some acute or long-term covariates may be prevented by 
the postponement of sampling (for state factors) or participant exclusion (for trait 
factors). Although we have made suggestions for how to deal with such parameters 
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(see 6.3), the decision about the most adequate strategy needs to consider the 
individual study context. 
Concerning the number of post-awakening sampling times, protocols including 
at least three assessments (on awakening, 30 min and 45 min) are recommended for 
research in adult populations to allow distinguishing between effects on CAR 
magnitude and the CAR peak timing. In research on children and pre-pubertal 
adolescents, the use of two-sample protocols (0 and 30 min) may be justifiable. In 
smaller scale, fundamental research on the CAR more extended sampling protocols 
are recommended to provide more comprehensive data on temporal dynamics of 
post-awakening cortisol secretion. In cross-sectional research, assessment of the 
CAR on an increased number of study days seems necessary to reliably capture trait 
components of the CAR. Specifically, researchers deciding to assess the CAR on 
only a single day need to be aware of the fact that 61–82% of variability in their 
results is likely to be due to state-specific factors. Such variability will decrease 
statistical power and restrict the detectable effect sizes for associations with trait 
measures in between-subject analyses. However, as long as state covariates are 
adequately dealt with this is unlikely to bias respective results. Hence, researchers 
need to trade off pros and cons of increasing the number of study days against those 
of increasing the sample size in terms of feasibility and cost considerations. A useful 
strategy in many cross-sectional study contexts is to assess the CAR on two 
weekdays and one weekend day.
Finally, regarding the reporting of post-awakening cortisol data, we 
recommend that results are provided separately for the two main assumed 
components: S1 (the first sample on awakening) and the CAR (the dynamic of the 
post-awakening cortisol response). Given the inverse association between S1 and 
the CAR, it may further be explored to control for S1 when analyzing the CAR. 
Composite measures reflecting total post-awakening cortisol levels (e.g., AUCG) may 
be reported as additional information but should be referred to as reflecting total 
‘post-awakening cortisol concentrations’, or similar, but not as estimates of the CAR. 
The term ‘cortisol awakening response’ should be restricted to measures of the 
dynamic of the post-awakening increase (e.g., AUCI, 0–30 delta, MnInc).
Overall, while the methodological considerations of this consensus statement 
may appear onerous, adherence to these steps is believed to create more powerful 
research designs that will yield reliable and reproducible data, thus increasing 
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researchers’ confidence in the validity of their findings and helping to further advance 
understanding in this evolving field of research. 
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